Apr 9, 2018
Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
Featuring: Peter Wilcox and Marian Wolanski
We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s blockbuster drug HUMIRA. This case was settled during the discovery phase as part of a global settlement between AbbVie and Samsung Bioepis.